On November 3rd, 2016, Inbiose, a Belgium-based producer of specialty carbohydrates and DuPont Nutrition & Health (DuPont, USA) announced a joint development and licensing agreement for exclusive rights to selected fucosylated human milk oligosaccharides (HMOs), including 2’-fucosyllactose. HMOs are a group of unique oligosaccharides found in mother’s milk, with 2’-fucosyllactose being the single most abundant […]
IB2Market, a public project funded by the European Union, brought a number of new-to-market and biobased molecules to the market. Several new types of bio-surfactants and specialty carbohydrates like Sophorose and Human Milk Sugars are now commercially available.
Today the Bio-Based Industries Joint Undertaking (BBI JU) launched a €6 million project entitled CARBOSURF with the aim to develop new processes and solve bottlenecks in the fermentative production of biobased biosurfactants and specialty carbohydrates. The new three-year project brings together 11 partners from 4 European countries: Research and Technology Organisations (RTOs), an open innovation pilot plant, four biotech SMEs and three large industries. The project received funding through the first call of the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme.
The CARBOSURF project aims to develop new biobased processes as well as products and solves bottlenecks in the fermentative production of biobased biosurfactants and specialty carbohydrates. Specifically, it targets different glycolipid biosurfactants with a wide range of application fields and specialty carbohydrates, i.e. complex Human Milk Oligosaccharides that find applications as neutraceutical, pharmaceutical and cosmetic ingredients. The project is coordinated by Prof. Soetaert from Ghent University (Belgium).
IB2Market aims to bring industrial biotechnology from the research lab to the market and to solve the bottle-necks in industrialization. The project covers process development, scale up, market exploration and the drafting of a valorization plan to support a successful market introduction.
The goal of the Novosides project is the development of biocatalytic processes for the glycosylation of small organic molecules such as flavonoids, alkaloids and steroids. Glycosylation can drastically improve both the physicochemical and biological properties of these molecules (e.g. slow release, improved solubility and stability, taste modification, drug targeting), but few biocatalysts are currently available to perform this modification cost-efficiently at industrial scale.